share_log

Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 223.0% in July

Defense World ·  Jul 28, 2022 02:41

Aethlon Medical, Inc. (NASDAQ:AEMD – Get Rating) was the recipient of a significant growth in short interest during the month of July. As of July 15th, there was short interest totalling 612,400 shares, a growth of 223.0% from the June 30th total of 189,600 shares. Based on an average daily trading volume, of 706,600 shares, the days-to-cover ratio is presently 0.9 days.

Analysts Set New Price Targets

Separately, StockNews.com began coverage on shares of Aethlon Medical in a research note on Saturday, July 16th. They set a "sell" rating on the stock.

Get Aethlon Medical alerts:

Institutional Trading of Aethlon Medical

An institutional investor recently bought a new position in Aethlon Medical stock. NTB Financial Corp acquired a new stake in Aethlon Medical, Inc. (NASDAQ:AEMD – Get Rating) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 17,425 shares of the medical equipment provider's stock, valued at approximately $32,000. NTB Financial Corp owned 0.11% of Aethlon Medical at the end of the most recent reporting period. Institutional investors own 10.58% of the company's stock.

Aethlon Medical Price Performance

AEMD opened at $1.06 on Thursday. Aethlon Medical has a one year low of $0.88 and a one year high of $5.99. The company's 50 day simple moving average is $1.12 and its 200-day simple moving average is $1.28. The stock has a market capitalization of $16.78 million, a P/E ratio of -1.51 and a beta of 0.87.

Aethlon Medical Company Profile

(Get Rating)

Aethlon Medical, Inc, a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes.

Further Reading

  • Get a free copy of the StockNews.com research report on Aethlon Medical (AEMD)
  • Shopify Stock Rallies Despite Quarterly Loss
  • Two Automation Stocks The Institutions Are Buying
  • Can Owens-Corning Insulate Your Portfolio?
  • Consumer Staple Kraft-Heinz Quietly Builds Momentum
  • Steady, Stable Kimberly-Clark Yields 3.4%

Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment